C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 121 filers reported holding C4 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,500 | -15.5% | 25,000 | +25.0% | 0.00% | – |
| Q2 2023 | $55,000 | +55.3% | 20,000 | +77.3% | 0.00% | -100.0% |
| Q1 2023 | $35,422 | -86.8% | 11,281 | -75.4% | 0.00% | -66.7% |
| Q4 2022 | $267,752 | -33.4% | 45,881 | 0.0% | 0.00% | -40.0% |
| Q3 2022 | $402,000 | +3.9% | 45,881 | -10.8% | 0.01% | 0.0% |
| Q2 2022 | $387,000 | -64.9% | 51,417 | +13.3% | 0.01% | -54.5% |
| Q1 2022 | $1,101,000 | -21.2% | 45,381 | +4.6% | 0.01% | -15.4% |
| Q4 2021 | $1,397,000 | – | 43,381 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |